| |
Latest 10 SEC filings (by transaction date) for ITCI within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 25/24 | Apr 24/24 | Mates Sharon | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -11,382 | |
Apr 25/24 | Apr 24/24 | Mates Sharon | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -8,638 | |
Apr 25/24 | Apr 24/24 | Mates Sharon | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 11,382 | $17.57 |
Apr 25/24 | Apr 24/24 | Mates Sharon | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 8,638 | $16.86 |
Apr 2/24 | Mar 31/24 | Van Nostrand Robert L | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 79 | $69.20 |
Apr 2/24 | Mar 31/24 | Riggs Rory B | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 260 | $69.20 |
Mar 22/24 | Mar 20/24 | Riggs Rory B | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -20,000 | |
Mar 22/24 | Mar 20/24 | Riggs Rory B | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 20,000 | $18.56 |
Mar 11/24 | Mar 11/24 | Mates Sharon | Direct Ownership | Common Stock | S - Open market or private sale | -306 | $67.33 |
Mar 11/24 | Mar 11/24 | Mates Sharon | Direct Ownership | Common Stock | S - Open market or private sale | -1,590 | $66.81 |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for ITCI within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Apr 25/24 | Apr 24/24 | Mates Sharon | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -11,382 | |
Apr 25/24 | Apr 24/24 | Mates Sharon | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -8,638 | |
Apr 25/24 | Apr 24/24 | Mates Sharon | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 11,382 | $17.57 |
Apr 25/24 | Apr 24/24 | Mates Sharon | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 8,638 | $16.86 |
Apr 2/24 | Mar 31/24 | Van Nostrand Robert L | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 79 | $69.20 |
Apr 2/24 | Mar 31/24 | Riggs Rory B | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 260 | $69.20 |
Mar 22/24 | Mar 20/24 | Riggs Rory B | Direct Ownership | Stock Option (right to buy) | M - Exercise or conversion exempt under rule 16b-3 | -20,000 | |
Mar 22/24 | Mar 20/24 | Riggs Rory B | Direct Ownership | Common Stock | M - Exercise or conversion exempt under rule 16b-3 | 20,000 | $18.56 |
Mar 11/24 | Mar 10/24 | Mates Sharon | Direct Ownership | Restricted Stock Units | M - Exercise or conversion exempt under rule 16b-3 | -20,565 | |
Mar 11/24 | Mar 11/24 | Mates Sharon | Direct Ownership | Common Stock | S - Open market or private sale | -306 | $67.33 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Apellis Pharmaceuticals (OQ:APLS) |
Biomarin Pharmaceutical (OQ:BMRN) |
Vericel (OQ:VCEL) |